Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Royal Prima Tbk. (PRIM) Price & Performance

UBC Medical Indonesia Tbk.Trade
Royal Prima Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Royal Prima Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Royal Prima Tbk. trades at Rp120 (market cap 397.03B, 3.81M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Royal Prima Tbk. is more actively traded (3.81M versus 635.5K). Which is the better fit depends on your goals.

LABSPRIM
Market Cap
691.25B397.03B
Volume
635.5K3.81M
Lot
6.36K38.09K
Turnover
110.15M449.6M
Average Price
173.33118.04
Value
110.15M449.6M
Indicative Equilibrium Price
174120
Indicative Equilibrium Volume
501

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PRIM
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Royal Prima Tbk.

PT Royal Prima (the Company) was established based on notarial deed No. 1 dated 4 June 2013 of Heriyanti, S.H., M.Kn., notary in Medan.

Read more on PRIM